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OBJECTIVES We sought to define the risks facing octogenarians undergoing contemporary percutaneous
coronary interventions (PCIs).
BACKGROUND The procedural risks of PCI for octogenarians have not been well established.
METHODS We compared the clinical characteristics and in-hospital outcomes of 7,472 octogenarians (mean
age 83 years) with those of 102,236 younger patients (mean age 62 years) who underwent PCI at
22 National Cardiovascular Network (NCN) hospitals from 1994 through 1997.
RESULTS Octogenarians had more comorbidities, more extensive coronary disease and a two- to
fourfold increased risk of complications, including death (3.8% vs. 1.1%), Q wave myocardial
infarction (1.9% vs. 1.3%), stroke (0.58% vs. 0.23%), renal failure (3.2% vs. 1.0%) and vascular
complications (6.7% vs. 3.3%) (p , 0.001 for all comparisons). Independent predictors of
procedural mortality in octogenarians included shock (odds ratio [OR] 5.4, 95% confidence
interval [CI] 3.3 to 8.8), acute myocardial infarction (OR 3.2, 95% CI 2.3 to 4.4), left
ventricular ejection fraction (LVEF) ,35% (OR 2.9, 95% CI 2.1 to 3.9), renal insufficiency
(OR 2.8, 95% CI 2.0 to 3.8), first PCI (OR 2.3, 95% CI 1.7 to 3.3), age .85 years (OR 2.1,
95% CI 1.5 to 2.7) and diabetes mellitus (OR 1.5, 95% CI 1.1 to 2.0). For elective procedures,
octogenarian mortality varied nearly 10-fold, and was strongly influenced by comorbidities
(0.79% mortality with no risk factors vs. 7.2% with renal insufficiency or LVEF ,35%).
Despite similar case-mix, PCI outcomes in octogenarians improved significantly over the four
years of observation (OR of 0.61 for death/myocardial infarction/stroke in 1997 vs. 1994; 95%
CI 0.45 to 0.85).
CONCLUSIONS Risks to octogenarians undergoing PCI are two- to fourfold higher than those of younger
patients, strongly influenced by comorbidities, and have decreased in the stent era. (J Am
Coll Cardiol 2000;36:723–30) © 2000 by the American College of Cardiology
Octogenarians (age $80 years) comprise the fastest growing
segment of the U.S. population (1,2). The high prevalence
of coronary disease in this age group (3–5), combined with
the dramatic growth of percutaneous coronary interventions
(PCIs) have resulted in more frequent use of these proce-
dures in the very elderly (6,7). Despite these trends, there
are limited outcomes data on the efficacy and safety of
contemporary PCIs in octogenarians. Randomized clinical
trials in interventional cardiology have enrolled very few
patients of this age, and observational studies have been
hampered by small sample sizes (7–22), giving rise to wide
confidence intervals on outcome variable estimates. Further-
more, patient case-mix has varied substantially between
these studies, and all but one report (22) predated coronary
stenting. As a result, PCI outcomes in octogenarians have
varied widely in the published data (mortality from 0% to
19%) (Table 1), and the contemporary risks in this age
group remain undefined.
Using the National Cardiovascular Network database
(NCN), we compared the outcomes of octogenarians un-
dergoing PCI with those of younger patients (,80 years
old). The multicenter nature of this data base afforded an
adequate sample size to study mortality and provided the
opportunity to sample outcomes across a large number of
interventional practices in the U.S. We also defined the
independent predictors of mortality for octogenarians and
the trends in their outcomes over the four-year period of
observation (1994 through 1997).
METHODS
NCN data base. The NCN is a multicenter collaboration
established in 1994 to foster global cardiovascular interven-
tional care contracts with large health care purchasers.
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Membership in NCN provides each institution with infor-
mation on patient case-mix, practice patterns, resource
utilization and procedure outcomes. Site-specific data are
reported in a blinded and confidential manner, thereby
promoting institutions to collect outcome data in an unbi-
ased manner. To become an NCN member, institutions
were required to meet a minimal annual procedure volume
benchmark of 300 PCIs. The NCN hospitals voluntarily
provided a central data coordinating center (Duke Univer-
sity, Durham, North Carolina) with routine data transfers
on all consecutive interventional procedures performed at
their centers during the study period. A list of the 22 NCN
centers providing outcomes data for this study can be found
in Appendix A.
Definition of variables. All demographic, clinical and
angiographic data variables were defined, a priori, by the
NCN Data Standards Committee. Procedure priority was
defined as urgent if the index PCI was required within 24 h
of presentation due to either unstable angina refractory to
nitroglycerin or ongoing myocardial ischemia. All other
procedures were considered elective. In-hospital mortality
was defined as the occurrence of death during the postpro-
cedural hospital phase. Myocardial infarction (MI) was
defined as the development of new Q waves in two or more
contiguous leads on a 12-lead electrocardiogram taken in
the hospital up to 30 days after PCI. Cerebrovascular accident
(CVA) was defined as a permanent loss of neurologic
function (including coma) caused by an ischemic vascular
event. Procedural success was defined as percent stenosis
reduction of at least 20% in all coronary stenoses intervened
upon, to ,50% residual diameter stenosis (i.e., angiographic
success), without the occurrence of death, MI or CVA after
the procedure. Repeat revascularization was defined as the
requirement for either emergency coronary artery bypass
graft surgery (CABG) or urgent repeat PCI after the index
intervention. Cardiogenic shock was defined as maximal
systolic pressure ,90 mm Hg for at least 30 min, unless
treated with inotropes or intra-aortic balloon pump inser-
tion, or pump failure as manifested by a cardiac index ,2.2
liter/min per m2 and pulmonary capillary wedge pressure
.18 mm Hg. Persistence of hypotension or pump failure
after correction of contributing extramyocardial factors (e.g.,
hypovolemia, hypoxemia, acidosis) and/or peripheral signs
of hypoperfusion (e.g., peripheral vasoconstriction, urine
output ,30 ml/h or altered sensorium) were also required.
Postprocedure renal failure was defined as oliguria (urine
output ,30 ml/h) or anuria associated with a daily increase
in serum creatinine and blood urea nitrogen of .1 mg/dl
and .10 mg/dl, respectively, or the need for either hemo-
dialysis or peritoneal dialysis at any time after the coronary
intervention. Vascular complications included any one of
the following: entry-site vessel occlusion, large groin hema-
toma prolonging the hospital stay, documented pseudoan-
eurysm formation, entry-site bleeding requiring transfusion
or surgical repair, dissection of the aorta, iliac or femoral
arteries or acute limb ischemia. Major blood loss was defined
as that requiring transfusion of blood products after the
procedure.
Coronary angiography was interpreted visually on site by
each operator. Left main coronary artery disease was defined
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CI 5 confidence interval
CVA 5 cerebrovascular accident
DCA 5 directional coronary atherectomy
LAD 5 left anterior descending coronary artery
LVEF 5 left ventricular ejection fraction
MI 5 myocardial infarction
NCN 5 National Cardiovascular Network
OR 5 odds ratio
PCI 5 percutaneous coronary intervention
Table 1. Studies Reporting Angioplasty Outcomes in Octogenarians
Reference (year) (ref.) n
Mean Age
(years)
Clinical Success
(%)
Mortality
(%)*
Kern (1988) (11) 21 82 67 19
Rizo-Patron (1990) (14) 53 83 83 1.9
Rich (1990) (13) 22 82 89 0
Jeroudi (1990) (10) 54 82 91 1.9
Myler (1991) (12) 74 82 90 1.4
Thompson (1991) (17) 193 79 93 6.2
Jackman (1991) (18) 31 82 90 3.2
ten Berg (1992) (19) 212 78 91 1.9
Santana (1992) (8) 53 .80 76 15
Bonnier (1993) 93 80 NA 4.0
Little (1993) (9) 118 83 93 4.6
Kaul (1994) (20) 150 84 89 8.6
Peterson (1994) (7) ;19,000† NA NA 7.8
Rozenman (1995) (15) 72 83 92 5.6
Lefevre (1998) (22) 233 79 NA 3.4
*All studies reported in-hospital mortality, except for Peterson (1994) and Lefevre (1998), who each reported 30-day mortality. †Calculated as 8.5% (proportion of octogenarians)
of overall sample of 222,915 patients undergoing PCI.
NA 5 not available.
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as $50% stenosis in the left main coronary artery. Stenoses
$70% were considered significant in all other coronary
arteries. Proximal left anterior descending coronary artery
(LAD) disease was defined as significant coronary stenosis in
the LAD proximal to the first septal perforator branch.
Percutaneous coronary revascularization procedures were
performed using conventional methods according to local
practice and operator discretion.
Statistical analysis. Clinical characteristics and in-hospital
outcomes were compared between the octogenarian cohort
and patients ,80 years old. In-hospital mortality was the
primary end-point evaluated; however, the duration of the
hospital stay (total and postprocedure lengths of hospital
phase) and the rates of procedural success, MI, CVA, the
composite of death/MI/CVA, renal failure, vascular com-
plications and urgent revascularization were also compared.
Variables were reported as the mean value 6 SD for
continuous variables or as percentages for dichotomous
variables. Comparisons between octogenarians and the
younger cohort were made using the chi-square test for
categoric variables and the t test for continuous variables.
Multivariable logistic regression analysis was used to
determine the baseline clinical and angiographic variables
independently associated with procedural mortality within
the octogenarian cohort. Variables were entered into the
model on the basis of a univariate association with proce-
dural mortality (p , 0.05), their clinical relevance, or both.
Continuous variables were examined for a linear fit within
the logistic regression models and were dichotomized when
the linearity assumption was not supported. All variables in
the final model were examined for pairwise interactions.
The model was internally validated using a bootstrap
method (23,24). For each of 100 bootstrap samples (samples
of the same size as the original study group but with patients
drawn randomly, with replacement, from the full study
group), the model was refit to estimate the degree to which
the predictive accuracy of the model would be expected to
deteriorate when applied to an independent sample of
patients (24). The final multivariable model was used to 1)
quantify the short-term mortality risk for an octogenarian
patient according to baseline clinical and angiographic
characteristics that are readily available at the time of the
procedure; 2) adjust the trends in outcome over time for any
imbalances in baseline risk; and 3) provide the basis for a
risk stratification scheme (25).
To examine trends in octogenarian outcomes over time,
we compared the risk-adjusted outcomes (rates of proce-
dural success, death, death/MI/CVA and vascular compli-
cations) in each of the last three years of the study (1995,
1996 and 1997) with outcomes from the first year of the
study (1994). These comparisons were graphically displayed
using odds ratio (OR) plots. Chi-square statistics were used
to test for differences in event rates over the four years of the
study. All statistical computations were performed using
SAS software (SAS Institute, Inc., Cary, North Carolina).
RESULTS
Clinical and angiographic characteristics. The baseline
clinical characteristics of the 7,472 octogenarians and the
102,236 younger patients are presented in Table 2. The
mean ages of the two groups were 83 and 62 years,
respectively. Octogenarians were more likely to be women
and Caucasian and to have their intervention performed for
urgent indications. Octogenarians were also more likely to
have other comorbid illnesses and indexes of severe coronary
disease (e.g., peripheral vascular disease, renal insufficiency,
cerebrovascular disease, congestive heart failure, previous
CABG and Canadian Cardiovascular Society class III or IV
angina), but were less likely to have diabetes mellitus or to
have had a previous PCI.
Baseline angiographic data are compared in Table 3. Left
ventricular systolic function was well preserved in both
cohorts, although the left ventricular ejection fraction
(LVEF) was slightly lower in octogenarians (mean LVEF
47% vs. 49%). Left main coronary artery disease was
uncommon in both groups. Octogenarians were more likely
to have disease of the proximal LAD and multivessel disease
(two- vs. three-vessel disease in 57% vs. 45%, respectively).
A similar proportion of each cohort had interventions
performed using stand-alone balloon angioplasty (;50% of
procedures) and coronary stenting (;40% of procedures).
Octogenarians were more likely to have a Rotablator pro-
cedure and less likely to have directional coronary atherec-
tomy (DCA). Laser angioplasty and other devices were used
with rarity (,1%) in both cohorts.
Clinical outcomes. The overall mortality for the entire
NCN study sample was 1.1%. Mortality demonstrated a
curvilinear relation with age, ranging from ;0.5% for
Table 2. Clinical Characteristics
Variable*
Age >80
years (n 5
7,472)
Age <80
years (n 5
102,236)
Mean (6SD) age (yrs) 83 6 2.4 62 6 11
Female 53 31
Caucasian 94 91
Procedure priority
Elective 68 72
Urgent 32 28
Shock 1.8 1.5
Acute MI 9.7 5.9
Previous MI 44 44
Congestive heart failure 16 8.3
Previous CABG 23 21
Previous PCI 30 34
CCS angina class III/IV 84 79
Hypertension 61 56
Diabetes mellitus 22 25
Cerebrovascular disease 14 7.8
Peripheral vascular disease 15 11
Renal insufficiency 9.8 4.8
*All data, except for age, are expressed as percentages. For all comparisons, p , 0.01,
except for previous MI (p 5 0.78).
CABG 5 coronary artery bypass graft surgery; CCS 5 Canadian Cardiovascular
Society; MI 5 myocardial infarction; PCI 5 percutaneous coronary intervention.
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patients ,55 years old to nearly 5% for patients .85 years
old (Fig. 1). The clinical outcomes of octogenarians com-
pared with those of the younger cohort are presented in
Table 4. Octogenarian mortality was relatively low, albeit
more than threefold that of the younger cohort (3.8% vs.
1.1%; OR 3.6, 95% confidence interval [CI] 3.2 to 4.1).
Procedural success was achieved in the majority of interven-
tions, although slightly less commonly in the octogenarian
cohort (84% vs. 89%, p , 0.001). Other in-hospital
complications occurred 1.5 to 3.5 times more frequently in
octogenarians, including the composite outcome of death/
MI/CVA (4.9% vs. 1.9%), Q wave MI (1.9% vs. 1.3%),
CVA (0.58% vs. 0.23%), renal failure (3.2% vs. 1.0%), major
blood loss (9.9% vs. 3.6%) and vascular complications (6.7%
vs. 3.3%). In-hospital repeat revascularization was per-
formed after ,5% of interventions in both age groups. The
total duration of the hospital stay was on average 1.4 days
longer for octogenarians, and the mean duration of the
hospital stay after the procedure was approximately one day
longer.
Predictors of mortality in octogenarians. Multivariable
logistic regression analysis (Table 5) revealed the following
independent predictors of in-hospital death for octogenarians
(in rank order of importance, using ORs): cardiogenic shock,
acute MI without shock, LVEF ,35%, renal insufficiency,
first PCI, age .85 years and diabetes mellitus. The C index for
the final model was 0.75, and the mean C index for the
bootstrap validation samples was also 0.75 (interquartile range
0.74 to 0.76), indicating internal validity of the model’s
predictive ability within our study sample.
We examined mortality after stratifying octogenarians
into risk groups created from the predictor variables iden-
tified by our regression model. Patients were grouped into a
single risk category by considering the presence or absence
of each independent mortality predictor sequentially, in
order of importance. Figure 2 displays the observed mortal-
ity within each of these groups, along with corresponding
95% CIs. Octogenarian mortality varied widely, from ,1%
to 31%, depending on coexisting risk factors. The vast
majority of procedures were performed electively (no shock
or acute MI). Within this group, mortality was low (2.2%)
but varied nearly 10-fold, from 0.79% (no risk factors) to
7.2% (renal insufficiency or impaired LVEF).
Trends in case-mix, device use and octogenarian out-
comes over time. The clinical case-mix of NCN patients,
including octogenarians, remained relatively constant over
the four study years. For example, the mean age, proportion
of women and prevalence of risk factors (diabetes, renal
disease, LVEF ,35% and age $85 years), as well as severity
of coronary disease, were comparable for octogenarians
across all years. Given the constancy of patient characteris-
tics over time, the predicted mortality risk for octogenarians
did not vary substantially over the four years. However, the
interventional techniques performed in octogenarians did
Table 3. Angiographic Characteristics
Variable*
Age > 80
years (n 5
7,472)
Age <80
years (n 5
102,236)
Mean (6SD) LVEF 47 6 14 49 6 13
LVEF ,35% 9.1 5.9
LMCA disease 7.3 5.7
Proximal LAD disease 24 20
Number of diseased
vessels
None 1.7 2.4
One 41 52
Two 28 25
Three 29 20
Mean (6SD) number of
vessels treated
1.5 6 0.78 1.4 6 0.74
Device†
Balloon PTCA alone 52 51
Stent 39 40
Rotablator 10 8.2
Atherectomy 2.8 4.4
Laser 1.4 1.4
Other 0.8 0.9
*All data, except for left ventricular ejection fraction (LVEF) and number of vessels
treated are reported as percentages. For all comparisons, p , 0.01, except for balloon
percutaneous transluminal coronary angioplasty (PTCA) alone (p 5 0.23), stent (p 5
0.20), laser (p 5 0.64) and other device use (p 5 0.50). †Groups are not mutually
exclusive; therefore, column percentages do not add to 100%.
LAD 5 left anterior descending coronary artery; LMCA 5 left main coronary
artery.
Figure 1. Observed rates of death/MI/CVA (dashed line) and mortality (solid line) according to age.
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change substantially over time. The rate of coronary stent
use increased from only 4% in the first quarter of 1994 to
over 66% in the last quarter of 1997. Over this time frame,
there was a corresponding decrease in atheroablative proce-
dures (DCA or Rotablator), from 18% to 5%.
In general, procedural outcomes in all patients improved
progressively over the time course of the study. However,
octogenarians showed a greater improvement in outcomes
over the four years of study than did younger patients (Table
6). Figure 3 illustrates the risk-adjusted likelihood of pro-
cedural success, death, death/MI/CVA and vascular com-
plications for octogenarians undergoing PCI during each of
the last three years (1995, 1996 and 1997) compared with
the first year (1994). There was a general trend toward
improved outcomes over time, such that by 1997 the
likelihood of procedural success had significantly increased
(OR 1.5, 95% CI 1.2 to 1.9) and the risk of death/MI/CVA
(OR 0.61, 95% CI 0.45 to 0.85) and vascular complications
(OR 0.64, 95% CI 0.45 to 0.93) had significantly decreased,
compared with 1994. The reduction in mortality between
1994 and 1997 also approached statistical significance (OR
0.71, 95% CI 0.49 to 1.03).
DISCUSSION
This study represents the largest procedural outcomes study
in octogenarians undergoing PCI in the era of intracoronary
stenting. We report that, with appropriate case selection,
these interventions can be performed with high rates of
procedural success and acceptably low mortality (3.8%) and
morbidity. However, the risks remain approximately two- to
fourfold higher in the very elderly as compared with younger
patients. For elective procedures, procedural risks vary
widely for octogenarians and are strongly influenced by
comorbidities such as left ventricular impairment, renal
insufficiency, diabetes mellitus and extreme age (age $85
years). The progressively higher procedural success rates,
associated with a 37% reduction in major cardiovascular
events (death/MI/stroke) over the four years of the study,
suggest that PCI outcomes in the very elderly have im-
proved over time. As these improved outcomes were not
attributable to shifts in case-mix and baseline risk, they are
more likely attributable to advances in interventional tech-
nique, operator skill or adjunctive medical therapy.
Comparisons with previous studies. As a part of the aging
process, coronary arteries are prone to dilation, tortuosity,
medial calcification and impairment of endothelial function
(26–29). These pathophysiologic alterations, in addition to
a higher prevalence of other cardiac and extracardiac comor-
bidities, have contributed to the lower success rates and
higher mortality reported for octogenarians undergoing
catheter-based coronary interventions (7–22). However, the
procedural mortality reported in our study is favorable as
compared with previous studies (Table 1). Most previous
reports have emerged from single academic institutional
experiences with small sample sizes (8,10–12), and all but
one (22) predated the use of intracoronary stenting, now
recognized as an effective technique in interventional cardi-
ology (30,31). The only other large-scale observational
study reported on the U.S. National Medicare experience
between 1987 to 1990, therefore also predating the use of
intracoronary stents (7). Of 225,915 Medicare patients
undergoing PCIs during this time frame, 8.5% (;19,000)
were octogenarians, and their 30-day mortality rate was
high (8%). Given the more contemporary time frame of our
study, as well as representation across a broad spectrum of
both community and academic interventional practices, we
feel that the short-term outcomes presented in our study are
more reflective of current interventional practices in the
United States at experienced institutions. In agreement with
Table 4. Clinical Outcomes
Outcome Age >80 years*
Age <80
years*
Odds Ratio
(95% CI)
p
Value
Death 3.8 (3.4–4.2) 1.1 (1.0–1.1) 3.6 (3.2–4.1) , 0.001
Procedural success 84 (83–85) 89 (89–89) 0.65 (0.60–0.70) , 0.001
Death/MI/CVA 4.9 (4.4–5.4) 1.9 (1.9–2.0) 2.6 (2.3–2.9) , 0.001
Q wave MI 1.9 (1.5–2.3) 1.3 (1.2–1.3) 1.5 (1.2–1.9) , 0.001
CVA 0.58 (0.38–0.78) 0.23 (0.2–0.26) 2.5 (1.7–3.6) , 0.001
Renal failure 3.2 (2.7–3.7) 1.0 (0.96–1.1) 3.1 (2.6–3.8) , 0.001
Vascular complication 6.7 (6.0–7.5) 3.3 (3.2–3.5) 2.1 (1.9–2.4) , 0.001
Urgent revascularization 4.4 (4.0–4.9) 4.5 (4.4–4.6) 0.98 (0.88–1.1) 0.770
Total LOS† 5.1 6 5.3 3.7 6 4.3 NA , 0.001
Postprocedure LOS† 3.6 6 4.6 2.6 6 3.8 NA , 0.001
*Data are expressed as percentages, with 95% confidence intervals in parentheses. †Length of hospital stay (LOS) in days (mean 6 SD).
CVA 5 cerebrovascular disease; MI 5 myocardial infarction; NA 5 not applicable.
Table 5. Multivariable Predictors of Octogenarian Mortality
Variable
Odds Ratio
(95% CI)
Chi-
Square
p
Value
Shock 5.4 (3.3–8.8) 45 , 0.001
Acute MI 3.2 (2.3–4.4) 46 , 0.001
LVEF ,35% 2.9 (2.1–3.9) 49 , 0.001
Renal insufficiency 2.8 (2.0–3.8) 39 , 0.001
First PTCA 2.3 (1.7–0.3.3) 24 , 0.001
Age .85 years 2.1 (1.5–2.7) 23 , 0.001
Diabetes mellitus 1.5 (1.1–2.0) 8.0 0.005
C index for predictive model 5 0.75. Mean bootstrap sample C index 5 0.75
(interquartile range 0.74 to 0.76).
CI 5 confidence interval; LVEF 5 left ventricular ejection fraction; MI 5
myocardial infarction; PTCA 5 percutaneous transluminal coronary angioplasty.
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our findings, the French Registry (22) recently reported a
similarly favorable short-term procedural mortality rate (3.4%)
for patients $75 years old undergoing coronary stenting.
Predictors of risk in octogenarians. Our study had an
adequate sample size to examine the independent predictors
of mortality for octogenarians undergoing coronary inter-
ventions. As expected, indicators of clinical stability such as
cardiogenic shock and acute MI were the strongest deter-
minants of mortality. The seven predictor variables defined
from our multivariable model (shock, acute MI, left ven-
tricular systolic function, renal insufficiency, first coronary
angioplasty, increased age and diabetes mellitus) bear some
similarity to those emerging from models previously devel-
oped from younger patients (32–34). The observation that
octogenarians who had a previous PCI faced less risk than
those undergoing their first procedure was interesting, but
could simply be due to the fact that survival from a first
procedure is requisite to having a second. Alternatively, it is
possible that the pathophysiology of restenosis lesions (in-
timal hyperplasia) may present a more stable plaque that is
more amenable to balloon dilation than is de novo athero-
sclerotic plaque.
Age, itself, was also an important independent outcome
predictor among octogenarians. “Older” octogenarians (age
$85 years) faced a twofold risk compared with “younger”
octogenarians (age ,85 years). In the development of our
risk model, we chose to represent age as a dichotomous
variable (,85 or $85 years), because the increase in risk was
most dramatic beyond age 85 years, and expressing age as a
continuous variable (even using higher order terms such as
Figure 2. Tree diagram illustrating the mortality risk for octogenarians stratified according to the independent predictors defined from the multivariable
model. Patients are included into only one risk group in a hierarchical manner (considering the presence of each risk factor in descending order of predictive
importance). The observed mortality and corresponding 95% CIs are presented at the bottom.
Table 6. Age-Specific Outcome Trends 1994–1997
1994 1995 1996 1997
Chi-Square
p Value*
Overall (n 5 109,708)
Death 1.4 1.3 1.2 1.2 0.11
Death/MI/CVA 2.2 2.3 2.1 2.0 0.027
Procedural success 86 88 89 90 0.011
Age ,80 years (n 5 102,236)
Death 1.2 1.2 1.0 1.0 0.12
Death/MI/CVA 1.9 2.2 1.8 1.9 0.03
Procedural success 86 89 90 90 0.001
Age $80 years (n 5 7,472)
Death 4.2 4.1 4.1 3.8 0.17
Death/MI/CVA 6.0 5.1 5.3 3.8 0.014
Procedural success 81 83 83 86 0.009
Data are expressed as percentages.
*The chi-square test (of association) defined the probability that the observed rates are the same for each year.
Abbreviations as in Table 4.
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age2 or age3) did not add significant predictive power to the
multivariable model, as compared with the use of the
dichotomous variable. Still, it must be recognized that the
procedural risk in octogenarians increases in a continuous,
curvilinear manner with increasing age.
An important insight from the predictive model was the
heterogeneity of risk observed for octogenarians. Risks were
relatively low under elective conditions (i.e., no shock or acute
MI) and in the absence of renal insufficiency or impaired left
ventricular systolic function. Indeed, it was the selection of
these “low risk” octogenarians that contributed to the favorable
octogenarian outcomes observed in this study. If validated in
other octogenarian cohorts, consideration of the seven inde-
pendent prognostic variables garnered from our model may
prove useful in quantifying risk and therefore assessing risk–
benefit relationships in elderly patients undergoing catheter-
based coronary interventions in the future.
Trends in octogenarian outcomes over time. Over the
four years of this study, procedural success rates for the
entire NCN cohort improved, and major procedural cardio-
vascular complications slightly decreased. Interestingly, the
greatest risk reduction over time was observed in octoge-
narians, where the risk of death and major cardiovascular
complications decreased by 29% and 37%, respectively. In
contrast, younger patients showed little change in what
began as a very low risk of mortality or major cardiovascular
complications over time. The favorable outcome trends
observed in octogenarians did not appear to be attributable
to changes in case-mix over time, because the clinical
characteristics, risk factors and predicted mortality of octo-
genarians remained relatively constant throughout the study
period (predicted mortality risk was 3.8% for both 1994 and
1997 in octogenarians). This phenomenon of improving
interventional outcomes in the elderly over time is consis-
tent with trends noted in the past decade (7,21) and may
have been a result of advances in interventional technique,
increasing operator experience or improved adjunctive med-
ical therapy (i.e., safe and more efficacious antiplatelet
therapies that replaced anticoagulation regimens during this
time). The dramatic increase in the use of intracoronary
stents in octogenarians during the four years of evaluation
(from only 6% in 1994 to .66% in 1997) suggests that this
technical advance may have been a major contributor to the
improved outcomes experienced during this period.
Study limitations. When assessing risk, it is possible that a
patient’s chronologic age, per se, may be less important than
the patient’s general physical condition (physiologic age).
Because case selection was left to the discretion of the operator,
there may have been a selection bias in favor of the lowest risk
octogenarians (i.e., those with the most favorable physiologic
age). However, octogenarians in this study were more symp-
tomatic (84% had Canadian Cardiovascular Society class
III/IV angina), had more extensive coronary artery disease
(57% had multivessel disease) and carried a substantially greater
burden of comorbidities than did younger patients. This
suggests that the elderly were truly a higher risk cohort. Lesion
characteristics (e.g., vessel size, tortuosity, thrombus, calcifica-
tion, lesion length) and periprocedural adjunctive medical
therapy (e.g., glycoprotein IIb/IIIa platelet receptor inhibitor
use or systemic anticoagulation) were not recorded in this data
base. Furthermore, postprocedure cardiac enzymes were not
systematically collected, so that only Q wave MI could be
assessed as an endpoint.
This study does not directly address whether elderly patients
with multivessel disease should undergo CABG or PCI.
However, given the longer duration of the hospital stay (.7
days) and high mortality (8%) and stroke rates (10%) observed
among octogenarians undergoing CABG in the same NCN
cohort (35), PCI may be a reasonable initial revascularization
strategy for octogenarians suitable for either procedure. With-
out direct comparative data, revascularization approaches must
continue to be made on an individual basis.
Like several other large national cardiovascular registries, the
NCN data base was not externally validated. However, all
institutions agreed to strict adherence to the specific variable
definitions that were defined a priori. Furthermore, institution-
specific outcomes were not released outside each institution,
thereby encouraging honest reporting of outcomes. Finally, it
should be emphasized that the results of this study are only
generalizable to selected octogenarians undergoing PCI in
high volume centers with experienced operators such as those
participating in the NCN collaboration.
Conclusions. The risks to octogenarians undergoing con-
temporary PCI are two- to fourfold higher than those of
younger patients, strongly influenced by comorbidities, and
appear to have declined during the era of coronary stenting.
The results of this report, as well as other studies that
provide insights into long-term outcomes, quality of life and
cost-effectiveness of coronary revascularization strategies,
are requisite to a more complete understanding of the
Figure 3. The relative odds of procedural success and in-hospital adverse
events (death, death/MI/CVA and vascular complications) are expressed as
adjusted OR with 95% CI for each year from 1995 through 1997, as compared
with the first year of data collection (1994). The ORs presented have been
adjusted for the seven variables in the multivariable mortality risk model.
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risk–benefit trade-off of these invasive interventions in this
rapidly growing segment of our population.
APPENDIX A
Participating Centers in the
National Cardiovascular Network Data Base
Duke University Medical Center, Durham, North Carolina;
Bryan Memorial Hospital, Lincoln, Nebraska; Albany Medical
Center Hospital, Albany, New York; Christ Hospital, Cincin-
nati, Ohio; Hillcrest Medical Center, Tulsa, Oklahoma;
Shadyside Hospital, Pittsburgh, Pennsylvania; St. John’s Hos-
pital, Springfield, Illinois; William Beaumont Hospital, Royal
Oak, Michigan; Abbott-Northwestern Hospital, Minneapolis,
Minnesota; St. Vincent’s Infirmary, Little Rock, Arkansas;
Mid America Heart Institute, Kansas City, Missouri; Mercy
Heart Institute, Sacramento, California; Washington Hospital
Center, Washington, District of Columbia; St. Luke’s Medical
Center, Milwaukee, Wisconsin; Emory Heart Center, Atlanta,
Georgia; Lenox Hill Hospital, New York, New York; Indiana
Heart Institute, Indianapolis, Indiana; Jewish Hospital Heart
and Lung Institute, Louisville, Kentucky; Maine Medical
Center, Portland, Maine; Florida Hospital, Orlando, Florida;
St. Thomas Hospital, Nashville, Tennessee; Baylor University
Hospital, Houston, Texas.
Reprint requests and correspondence: Dr. Wayne B. Batchelor,
Terrence Donnelly Heart Center, St. Michael’s Hospital, 30 Bond
Street, Toronto, Ontario, Canada.
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